Mthera Pharma Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
9
Mthera Pharma General Information
Description
Developer of a pre-clinical drug intended to accelerate the translation of innovative science into transformative precision medicine. The company's lead compounds accelerate a multi-target disease approach, enabling doctors to tackle Parkinson's and dementia.
Contact Information
Website
www.mtherapharma.comCorporate Office
- Number 102, 38 Magokjungang 8-ro 1-gil
- Gangseo-gu
- Seoul, 07793
- South Korea
Corporate Office
- Number 102, 38 Magokjungang 8-ro 1-gil
- Gangseo-gu
- Seoul, 07793
- South Korea
Mthera Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Accelerator/Incubator | 25-Oct-2023 | Completed | Generating Revenue | |||
| 7. Early Stage VC (Series B1) | 01-Aug-2022 | Completed | Generating Revenue | |||
| 6. Early Stage VC (Series B) | 24-Dec-2021 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series A) | 31-Mar-2021 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jan-2021 | Completed | Generating Revenue | |||
| 3. Seed Round | 17-Jun-2020 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 12-Jun-2020 | Completed | Generating Revenue | |||
| 1. Seed Round | 04-Mar-2020 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Mthera Pharma Patents
Mthera Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023239175-A1 | Composition for preventing or treating alphaherpesvirus, gammaherpesvirus or norovirus infectious disease comprising extract of tsuga sieboldii, potentilla discolor bunge, potentilla nivea l., hydrocotyle yabei makino, or anthriscus sylvestris | Inactive | 08-Jun-2022 | ||
| WO-2023214819-A1 | Composition for preventing or treating psoriasis comprising isatidis folium extract | Inactive | 04-May-2022 | ||
| EP-4458366-A1 | Composition for treating inflammatory bowel disease, comprising combined extract of isatidis folium and juglans mandshurica | Pending | 27-Dec-2021 | ||
| EP-4458366-A4 | Composition for treating inflammatory bowel disease, comprising combined extract of isatidis folium and juglans mandshurica | Pending | 27-Dec-2021 | ||
| US-20240342235-A1 | Composition for treating inflammatory bowel disease, comprising combined extract of isatidis folium and juglans mandshurica | Pending | 27-Dec-2021 | A23K10/30 |
Mthera Pharma Signals
Mthera Pharma Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Daepyung | Corporation | Minority | ||
| Genaxis (Korea) | Venture Capital | Minority | ||
| TONY Investment | Venture Capital | Minority | ||
| Woori Technology Investment Company | Venture Capital | Minority | ||
| COMEUP STARS | Accelerator/Incubator |
Mthera Pharma FAQs
-
When was Mthera Pharma founded?
Mthera Pharma was founded in 2020.
-
Where is Mthera Pharma headquartered?
Mthera Pharma is headquartered in Seoul, South Korea.
-
What is the size of Mthera Pharma?
Mthera Pharma has 6 total employees.
-
What industry is Mthera Pharma in?
Mthera Pharma’s primary industry is Drug Discovery.
-
Is Mthera Pharma a private or public company?
Mthera Pharma is a Private company.
-
What is Mthera Pharma’s current revenue?
The current revenue for Mthera Pharma is .
-
How much funding has Mthera Pharma raised over time?
Mthera Pharma has raised $11.2K.
-
Who are Mthera Pharma’s investors?
Daepyung, Genaxis (Korea), TONY Investment, Woori Technology Investment Company, and COMEUP STARS are 5 of 9 investors who have invested in Mthera Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process